Delivery Order SPE2DB22D3016-SPE2DB24FBCL8
Award Date
7/29/24
Potential Completion Date
7/30/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,666.41, is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of HEMABATE 250 MCG/ML AMPULML medical products. The contract has a ceiling value of $3,567.20 and an ultimate completion date of June 11, 2025. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a ceiling value of $1,656.93 and a performance period through May 28, 2025. The contract is not set-aside and was awarded on May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is a firm fixed price delivery order (SPE2DB20D1100|SPE2DB24FA8J4) issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, with a ceiling value of $12,900.22 and a performance period through March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
This federal contract award is for the delivery of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025 with a ceiling value of $1,695.80. The contract has a firm fixed price pricing type and an ultimate completion date of February 27, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical worth $5,346.88 to supply 250 mcg/ml ampules of Hemabate. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all products delivered by November 16, 2023. No set-aside designation was applied to this award made against an existing DLA contract vehicle. Amerisourcebergen specializes in providing pharmaceuticals and...
The Defense Logistics Agency (DLA) awarded a $9,940.80 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of HEMANGEOL 4.28 MG/ML ORAL SOLN 120ML, a pharmaceutical product, with a period of performance through September 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, for providing a comprehensive...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price delivery order to Amerisourcebergen Drug Corp's Corporate Office division. The order, valued at $68,052.48, is for the supply of pharmaceutical products and medical supplies to support federal healthcare programs and military treatment facilities. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract held by Amerisourcebergen with the DLA Troop Support...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract worth $46,978.10 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract is for the supply of various pharmaceutical products and medical supplies to support healthcare needs for military treatment programs and facilities worldwide. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,251.55 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of various pharmaceutical products and medical supplies to support federal healthcare programs and military treatment facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through...